BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 1899810)

  • 1. The potent anti-tumor-promoting agent isoliquiritigenin.
    Yamamoto S; Aizu E; Jiang H; Nakadate T; Kiyoto I; Wang JC; Kato R
    Carcinogenesis; 1991 Feb; 12(2):317-23. PubMed ID: 1899810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-tumor promoting action of phthalic acid mono-n-butyl ester cupric salt, a biomimetic superoxide dismutase.
    Yamamoto S; Nakadate T; Aizu E; Kato R
    Carcinogenesis; 1990 May; 11(5):749-54. PubMed ID: 2110512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition by lipoxygenase inhibitors of 7-bromomethylbenz[a]anthracene-caused epidermal ornithine decarboxylase induction and skin tumor promotion in mice.
    Nakadate T; Yamamoto S; Aizu E; Kato R
    Carcinogenesis; 1989 Nov; 10(11):2053-7. PubMed ID: 2553289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential inhibition by staurosporine, a potent protein kinase C inhibitor, of 12-O-tetradecanoylphorbol-13-acetate-caused skin tumor promotion, epidermal ornithine decarboxylase induction, hyperplasia and inflammation.
    Yamamoto S; Kiyoto I; Aizu E; Nakadate T; Hosoda Y; Kato R
    Carcinogenesis; 1989 Jul; 10(7):1315-22. PubMed ID: 2544313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of two-stage skin carcinogenesis as well as complete skin carcinogenesis by oral administration of TMK688, a potent lipoxygenase inhibitor.
    Jiang H; Yamamoto S; Kato R
    Carcinogenesis; 1994 May; 15(5):807-12. PubMed ID: 8200079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of 7-bromomethylbenz[a]anthracene-promoted mouse skin tumor formation by retinoic acid and dexamethasone.
    Verma AK; Garcia CT; Ashendel CL; Boutwell RK
    Cancer Res; 1983 Jul; 43(7):3045-9. PubMed ID: 6406052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activity by phospholipase A2 inhibitors and lipoxygenase inhibitor.
    Nakadate T; Yamamoto S; Ishii M; Kato R
    Cancer Res; 1982 Jul; 42(7):2841-5. PubMed ID: 6805948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of prostaglandin E2 in ornithine decarboxylase induction by a tumor-promoting agent, 7-bromomethylbenz[a]anthracene, in mouse epidermis.
    Yamamoto S; Jiang H; Otsuka C; Kato R
    Carcinogenesis; 1992 May; 13(5):905-6. PubMed ID: 1587007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tumor-promoting action of FK506, a potent immunosuppressive agent.
    Jiang H; Yamamoto S; Nishikawa K; Kato R
    Carcinogenesis; 1993 Jan; 14(1):67-71. PubMed ID: 7678785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of flavonoids and antioxidants on 12-O-tetradecanoyl-phorbol-13-acetate-caused epidermal ornithine decarboxylase induction and tumor promotion in relation to lipoxygenase inhibition by these compounds.
    Nakadate T; Yamamoto S; Aizu E; Kato R
    Gan; 1984 Mar; 75(3):214-22. PubMed ID: 6427052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-mediated epidermal ornithine decarboxylase induction and skin tumor promotion by new lipoxygenase inhibitors lacking protein kinase C inhibitory effects.
    Aizu E; Nakadate T; Yamamoto S; Kato R
    Carcinogenesis; 1986 Nov; 7(11):1809-12. PubMed ID: 3094975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activity and tumor promotion by N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7) in mouse skin.
    Nakadate T; Yamamoto S; Aizu E; Kato R
    Pharmacology; 1986; 32(3):167-75. PubMed ID: 3083437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of mouse epidermal ornithine decarboxylase activity and skin tumors by 7,12-dimethylben.
    Verma AK; Conrad EA; Boutwell RK
    Carcinogenesis; 1980 Jul; 1(7):607-11. PubMed ID: 11219836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-caused tumor promotion in 7,12-dimethylbenz[a]anthracene-initiated SENCAR mouse skin by a polyphenolic fraction isolated from green tea.
    Katiyar SK; Agarwal R; Wood GS; Mukhtar H
    Cancer Res; 1992 Dec; 52(24):6890-7. PubMed ID: 1458478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of combined treatments with selenium, glutathione, and vitamin E on glutathione peroxidase activity, ornithine decarboxylase induction, and complete and multistage carcinogenesis in mouse skin.
    Perchellet JP; Abney NL; Thomas RM; Guislain YL; Perchellet EM
    Cancer Res; 1987 Jan; 47(2):477-85. PubMed ID: 3098411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anthocyanin- and hydrolyzable tannin-rich pomegranate fruit extract modulates MAPK and NF-kappaB pathways and inhibits skin tumorigenesis in CD-1 mice.
    Afaq F; Saleem M; Krueger CG; Reed JD; Mukhtar H
    Int J Cancer; 2005 Jan; 113(3):423-33. PubMed ID: 15455341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xanthorrhizol inhibits 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation and two-stage mouse skin carcinogenesis by blocking the expression of ornithine decarboxylase, cyclooxygenase-2 and inducible nitric oxide synthase through mitogen-activated protein kinases and/or the nuclear factor-kappa B.
    Chung WY; Park JH; Kim MJ; Kim HO; Hwang JK; Lee SK; Park KK
    Carcinogenesis; 2007 Jun; 28(6):1224-31. PubMed ID: 17234720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid.
    Huang MT; Ho CT; Wang ZY; Ferraro T; Lou YR; Stauber K; Ma W; Georgiadis C; Laskin JD; Conney AH
    Cancer Res; 1994 Feb; 54(3):701-8. PubMed ID: 8306331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition by putrescine of the induction of epidermal ornithine decarboxylase activity and tumor promotion caused by 12-O-tetradecanoylphorbol-13-acetate.
    Weekes RG; Verma AK; Boutwell RK
    Cancer Res; 1980 Nov; 40(11):4013-8. PubMed ID: 7471050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activity by lipoxygenase inhibitors: possible role of product(s) of lipoxygenase pathway.
    Nakadate T; Yamamoto S; Ishii M; Kato R
    Carcinogenesis; 1982; 3(12):1411-4. PubMed ID: 6817941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.